breseq version 0.35.4 revision f352f80f4bc9
mutation predictions | marginal predictions | summary statistics | genome diff | command line log |
Marginal read alignment evidence | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
seq id | position | ref | new | freq | score (cons/poly) | reads | annotation | genes | product | ||
* | NC_000913_3_bme_pgi | 526,800 | 0 | A | G | 41.9% | 29.3 / 34.5 | 43 | E1180E (GAA→GAG) | rhsD | Rhs protein with DUF4329 family putative toxin domain; putative neighboring cell growth inhibitor |
* | NC_000913_3_bme_pgi | 526,796 | 0 | C | G | 40.9% | 38.6 / 43.3 | 45 | A1179G (GCG→GGG) | rhsD | Rhs protein with DUF4329 family putative toxin domain; putative neighboring cell growth inhibitor |
* | NC_000913_3_bme_pgi | 526,792 | 0 | A | C | 38.8% | 36.4 / 38.1 | 50 | S1178R (AGC→CGC) | rhsD | Rhs protein with DUF4329 family putative toxin domain; putative neighboring cell growth inhibitor |
* | NC_000913_3_bme_pgi | 4,296,061 | 0 | C | T | 37.1% | 59.3 / 75.9 | 90 | intergenic (+266/+376) | gltP/yjcO | glutamate/aspartate:proton symporter/Sel1 family TPR‑like repeat protein |
Marginal new junction evidence (lowest skew 10 of 79 shown) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
seq id | position | reads (cov) | reads (cov) | score | skew | freq | annotation | gene | product | ||
* | ? | NC_000913_3_bme_pgi | = 274419 | NA (NA) | 10 (0.230) | 8/280 | 4.5 | NA | coding (699/1017 nt) | insH1 | IS5 transposase and trans‑activator |
? | NC_000913_3_bme_pgi | = 274423 | NA (NA) | coding (695/1017 nt) | insH1 | IS5 transposase and trans‑activator | |||||
* | ? | NC_000913_3_bme_pgi | = 4171607 | 22 (0.490) | 7 (0.160) | 7/278 | 4.9 | 24.9% | intergenic (+63/‑30) | rrlB/rrfB | 23S ribosomal RNA of rrnB operon/5S ribosomal RNA of rrnB operon |
? | NC_000913_3_bme_pgi | = 4213022 | NA (NA) | intergenic (+76/‑18) | rrlE/rrfE | 23S ribosomal RNA of rrnE operon/5S ribosomal RNA of rrnE operon | |||||
* | ? | NC_000913_3_bme_pgi | = 3946688 | 48 (1.060) | 7 (0.160) | 7/278 | 4.9 | 13.2% | intergenic (+81/‑12) | rrlC/rrfC | 23S ribosomal RNA of rrnC operon/5S ribosomal RNA of rrnC operon |
? | NC_000913_3_bme_pgi | = 4171601 | NA (NA) | intergenic (+57/‑36) | rrlB/rrfB | 23S ribosomal RNA of rrnB operon/5S ribosomal RNA of rrnB operon | |||||
* | ? | NC_000913_3_bme_pgi | 2726200 = | NA (NA) | 7 (0.160) | 7/278 | 4.9 | NA | intergenic (‑12/+81) | rrfG/rrlG | 5S ribosomal RNA of rrnG operon/23S ribosomal RNA of rrnG operon |
? | NC_000913_3_bme_pgi | 2726224 = | NA (NA) | intergenic (‑36/+57) | rrfG/rrlG | 5S ribosomal RNA of rrnG operon/23S ribosomal RNA of rrnG operon | |||||
* | ? | NC_000913_3_bme_pgi | = 228744 | 38 (0.840) | 7 (0.160) | 7/278 | 4.9 | 16.1% | intergenic (+82/‑12) | rrlH/rrfH | 23S ribosomal RNA of rrnH operon/5S ribosomal RNA of rrnH operon |
? | NC_000913_3_bme_pgi | 2726224 = | NA (NA) | intergenic (‑36/+57) | rrfG/rrlG | 5S ribosomal RNA of rrnG operon/23S ribosomal RNA of rrnG operon | |||||
* | ? | NC_000913_3_bme_pgi | 1018972 = | 51 (1.130) | 5 (0.120) | 5/268 | 5.6 | 9.9% | intergenic (+35/+41) | matP/ompA | Ter macrodomain organizer matS‑binding protein/outer membrane protein A (3a;II*;G;d) |
? | NC_000913_3_bme_pgi | 1018998 = | 44 (1.050) | intergenic (+61/+15) | matP/ompA | Ter macrodomain organizer matS‑binding protein/outer membrane protein A (3a;II*;G;d) | |||||
* | ? | NC_000913_3_bme_pgi | 3705963 = | NA (NA) | 5 (0.120) | 5/276 | 5.8 | NA | noncoding (1/98 nt) | RIP266 (repetitive extragenic palindromic) element; contains 2 REP sequences and 1 IHF site | RIP266 (repetitive extragenic palindromic) element; contains 2 REP sequences and 1 IHF site |
? | NC_000913_3_bme_pgi | 3705993 = | NA (NA) | noncoding (31/98 nt) | RIP266 (repetitive extragenic palindromic) element; contains 2 REP sequences and 1 IHF site | RIP266 (repetitive extragenic palindromic) element; contains 2 REP sequences and 1 IHF site | |||||
* | ? | NC_000913_3_bme_pgi | 2068389 = | 57 (1.260) | 4 (0.100) | 4/254 | 5.9 | 7.6% | pseudogene (31/159 nt) | yoeH | pseudogene, CP4‑44 putative prophage remnant;Phage or Prophage Related |
? | NC_000913_3_bme_pgi | 2068430 = | 47 (1.180) | intergenic (‑11/‑205) | yoeH/yoeA | pseudogene, CP4‑44 putative prophage remnant;Phage or Prophage Related/CP4‑44 prophage; putative disrupted hemin or colicin receptor;Phage or Prophage Related; interrupted by IS2 and C‑terminal deletion | |||||
* | ? | NC_000913_3_bme_pgi | 137965 = | 40 (0.880) | 5 (0.110) | 5/282 | 5.9 | 11.0% | coding (883/1551 nt) | cueO | multicopper oxidase (laccase) |
? | NC_000913_3_bme_pgi | 137989 = | 42 (0.950) | coding (907/1551 nt) | cueO | multicopper oxidase (laccase) | |||||
* | ? | NC_000913_3_bme_pgi | 3798221 = | 59 (1.300) | 4 (0.100) | 4/264 | 6.1 | 7.2% | intergenic (+14/+18) | waaL/waaU | O‑antigen ligase/lipopolysaccharide core biosynthesis |
? | NC_000913_3_bme_pgi | 3798249 = | 50 (1.210) | coding (1064/1074 nt) | waaU | lipopolysaccharide core biosynthesis |